Author
DEAN, H - SCHERING-PLOUGH ANIM HLTH | |
LEYH, R - SCHERING-PLOUGH ANIM HLTH | |
GOODYEAR, M - SCHERING-PLOUGH ANIM HLTH | |
SOCKETT, D - WISCONSIN ANIM HLTH LAB | |
Bolin, Steven - Steve | |
CARTER, D - VETERINARY RESOURCES, INC | |
EGAN, M - SCHERING-PLOUGH ANIM HLTH | |
WARTHEN, M - SCHERING-PLOUGH ANIM HLTH |
Submitted to: Research Workers in Animal Diseases Conference Proceedings
Publication Type: Abstract Only Publication Acceptance Date: 11/11/1997 Publication Date: N/A Citation: N/A Interpretive Summary: Technical Abstract: The ability of a virulent field isolate of bovine viral diarrhea virus type 2 (BVDV2) to produce clinical signs and hemotologic changes in beef calves was investigated. The isolate, identified as BVDV2(WAHL-95), was obtained from a Wisconsin dairy herd undergoing a severe outbreak of BVDV2. Three doses of challenge virus were used in an attempt to determine a dose that would be sufficient to cause reproducible disease. BVDV2(WAHL-95) caused severe disease and mortalities at dose levels as low as 3.6 log10FAID50/calf. The virus caused severe thrombocytopenia and leukopenia in antibody positive and negative calves. Virus shedding and viremia occurred at all dose levels. Some calves failed to seroconvert following challenge. Clinical signs included respiratory distress/nasal secretions, diarrhea, oral ulcers, and mortality in all dose levels tested. These results demonstrate the susceptibility of beef as well as dairy breeds to contemporary virulent field isolates of BVDV2. |